Pentwater Capital Management LP 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:42 pm Sale | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Pentwater Capital Management LP | 722,580 2.590% | -1,545,681 (-68.14%) | Filing |